biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0b5-01a-11d-a12q-09
biospecimen_aliquot__bcr_aliquot_uuid	dfa0f8ea-ae94-4673-9751-f6cdad26022a
biospecimen_aliquot__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108431853
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-02-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a12q
biospecimen_aliquot__plate_row	e
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.98
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0b5-01a-11d
biospecimen_analyte__bcr_analyte_uuid	81ed91ed-ed11-4306-9511-b5038893d86e
biospecimen_analyte__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0b5
biospecimen_diagnostic_slides__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	742db0e8-8eb1-47c8-b698-8e2438fb6299
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0b5
biospecimen_normal_control__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0b5-01a-11
biospecimen_portion__bcr_portion_uuid	1548ff2d-809f-479e-8ad1-fdff952db1ea
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_portion__date_of_creation	2010-11-17
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0b5-01a-11d
biospecimen_protocol__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_sample__bcr_sample_uuid	a0de3018-8916-4e06-8ba1-beb1d218e30e
biospecimen_sample__days_to_collection	1008
biospecimen_sample__initial_weight	700
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0b5.f44c515d-5a58-4382-a147-4429a78d434f.pdf
biospecimen_sample__pathology_report_uuid	f44c515d-5a58-4382-a147-4429a78d434f
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_shipment_portion__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	e6f7c6af-6c88-4305-a8f4-d8ea46f8b302
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13c
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-bh-a0b5-01a-21-a13c-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0b5-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0b5-01a-01-bsa
biospecimen_slide__bcr_slide_uuid	6fc7f4e6-e267-4359-b472-057f1e77ae1a
biospecimen_slide__image_file_name	tcga-bh-a0b5-01a-01-bsa.6fc7f4e6-e267-4359-b472-057f1e77ae1a.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	1
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	29
biospecimen_slide__percent_stromal_cells	40
biospecimen_slide__percent_tumor_cells	30
biospecimen_slide__percent_tumor_nuclei	45
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0b5
biospecimen_tumor_sample__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
clinical_drug__bcr_drug_barcode	tcga-bh-a0b5-d59183
clinical_drug__bcr_drug_uuid	17d3063f-cc13-421e-a738-803d7c558475
clinical_drug__bcr_patient_barcode	tcga-bh-a0b5
clinical_drug__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
clinical_drug__form_completion_date	2014-5-2
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	63
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0b5-f59182
clinical_follow_up__bcr_followup_uuid	994e9dc9-8cdf-461e-a2db-c42a64512ae8
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0b5
clinical_follow_up__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-5-2
clinical_follow_up__last_contact_days_to	2136
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	40
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n2a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left
clinical_patient__bcr_patient_barcode	tcga-bh-a0b5
clinical_patient__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
clinical_patient__birth_days_to	-14920
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-8-2
clinical_patient__gender	female
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2007
clinical_patient__last_contact_days_to	1471
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	24
clinical_patient__lymph_nodes_examined_he_count	5
clinical_patient__margin_status	positive
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	fine needle aspiration biopsy
clinical_patient__patient_id	a0b5
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a0b5
clinical_radiation__bcr_patient_uuid	9da462b0-93c2-4305-89f6-7199a30399a7
clinical_radiation__bcr_radiation_barcode	tcga-bh-a0b5-r59186
clinical_radiation__bcr_radiation_uuid	0b41a50f-764d-4d7c-bc17-e313c18aa5f6
clinical_radiation__form_completion_date	2014-5-2
clinical_radiation__radiation_adjuvant_fractions_total	28
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	302
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	257
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	5040
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0B5-01A-11D-A12Q-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0B5-01A-11D-A12Q-09.bed.meta
manually_curated__id	tcga-bh-a0b5-01a-11d-a12q-09
manually_curated__md5sum	66c6c37f23cf0f4cc1c288d1a18291ed
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	dfa0f8ea-ae94-4673-9751-f6cdad26022a
manually_curated__tumor_tag	brca
